NCT04234893 is a clinical trial in Coronary Stenosis, sponsored by Yinyi(Liaoning) Biotech Co., Ltd..

Who is sponsoring NCT04234893?

NCT04234893 is sponsored by Yinyi(Liaoning) Biotech Co., Ltd..

What condition does NCT04234893 study?

NCT04234893 studies Coronary Stenosis, Drug-coated Balloon, De Novo Stenosis, Coronary Artery Disease in Transplanted Heart Accelerated.

Is NCT04234893 still recruiting?

NCT04234893 is currently completed. Last updated 27 May 2022.

Last reviewed 2022-05-27 · How we verify

NCT04234893

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bingo Drug-Coated Balloon in Real World

Completed Last updated 27 May 2022

What this trial tests

trial in Coronary Stenosis in 805 participants. Completed in 4 May 2022.

Timeline

3 June 2019

Primary endpoint
4 June 2021

4 May 2022

Quick facts

Lead sponsor	Yinyi(Liaoning) Biotech Co., Ltd.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	805
Start date	3 June 2019
Primary completion	4 June 2021
Estimated completion	4 May 2022
Sites	1 location across China

Conditions studied

Coronary Stenosis — all drugs for Coronary Stenosis →
Drug-coated Balloon — all drugs for Drug-coated Balloon →
De Novo Stenosis — all drugs for De Novo Stenosis →
Coronary Artery Disease in Transplanted Heart Accelerated — all drugs for Coronary Artery Disease in Transplanted Heart Accelerated →

Sponsor

Yinyi(Liaoning) Biotech Co., Ltd.

Who can join

18 and older, any sex, with Coronary Stenosis or Drug-coated Balloon. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose is to observe and evaluate the safety and efficacy of Bingo drug-coated balloon in the real world.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Coronary Stenosis

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT06542393 — PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG) · Phase 2 · recruiting
NCT05709652 — Impact of Fast-rotation Coronary CT in Patients Undergoing Aortic Stenosis Workup · NA · recruiting
NCT06376630 — Study of Microvascular Dysfunction, CFR and Cardioprotective Effect of Early Administration of Esmolol in MI · NA · recruiting
NCT04014140 — iFR Guided Coronary Artery Bypass Grafting Surgery · recruiting

Other Yinyi(Liaoning) Biotech Co., Ltd. trials

Trials by the same sponsor.

NCT06441539 — Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions · NA · not yet recruiting
NCT04821726 — DEB for Symptomatic Intracranial Atherosclerosis Stenosis · NA · unknown
NCT02325817 — Bingo Drug-eluting Balloon in Bifurcation · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04234893 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yinyi(Liaoning) Biotech Co., Ltd.
Last refreshed: 27 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04234893.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing